Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Seagen Inc.
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
BeiGene
Stanford University
University of Nebraska
Eastern Cooperative Oncology Group
Columbia University
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Seagen Inc.
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Mayo Clinic
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Mayo Clinic
University of Chicago
Case Comprehensive Cancer Center
Swiss Cancer Institute
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins